Delivery Order SPE2DB22D3016-SPE2DB25FBDS0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $85,300.56 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TAGRISSO is an oncology medication used for treating certain types of lung cancer,...
- The Defense Logistics Agency awarded a delivery order valued at $10,641.07 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 40 mg tablets (30-count units) under a firm fixed price contract. This delivery order, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, represents a non-set-aside, competitively awarded procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TAGRISSO is a prescription...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count supply) valued at approximately $53.3K. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 14, 2025, awarded on July 24, 2025. The pharmaceutical product will be supplied to the federal government through AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count packaging) on July 29, 2025, with an ultimate completion date of August 19, 2025. The contract employs firm fixed-price pricing and was not issued under any set-aside designation, indicating competitive award through open competition. Performance of this delivery order is based at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at approximately $32,000 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of August 15, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in...
- The Defense Logistics Agency awarded a delivery order valued at $21,325.14 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order was issued on July 22, 2025, with an ultimate completion date of August 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters and primary distribution center. Tagrisso (osimertinib) is an advanced...
- The Defense Logistics Agency awarded a delivery order valued at $31,987.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition, reflecting the contractor's capability to meet federal procurement standards. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $21,325.14 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). The contract is firm fixed price with no set-aside designation, reflecting a competitive award. Performance will be completed by August 20, 2025, with the contract awarded on July 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $31,616.37 firm-fixed-price delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of August 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for TAGRISSO 40 mg tablets (30-count packages). The contract, valued at $10,641.07, is scheduled for completion by August 13, 2025, and represents a non-competitive set-aside delivery order placed against the company's existing Indefinite Delivery Contract with DLA. This award falls under...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDS0Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $21,325.14 for TAGRISSO 80 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TAGRISSO is a prescription oncology medication used primarily in the treatment of certain types of lung cancer, reflecting the critical role pharmaceutical distributors play in supporting federal healthcare procurement for military and veteran populations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. As a prime vendor for pharmaceutical supply to the Defense Health Agency and other federal healthcare systems, AmerisourceBergen leverages this comprehensive global contract vehicle to distribute a broad portfolio of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains in support of worldwide military healthcare programs. The company's substantial prime contract demonstrates its capacity to fulfill diverse federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.3k | 7/31/25 |